Hydreight Technologies Statistics

Total Valuation

TSXV:NURS has a market cap or net worth of CAD 143.61 million. The enterprise value is 133.30 million.

Market Cap	143.61M
Enterprise Value	133.30M

Important Dates

The next estimated earnings date is Friday, May 1, 2026.

Earnings Date	May 1, 2026
Ex-Dividend Date	n/a

Share Statistics

TSXV:NURS has 53.39 million shares outstanding. The number of shares has increased by 13.27% in one year.

Current Share Class	53.39M
Shares Outstanding	53.39M
Shares Change (YoY)	+13.27%
Shares Change (QoQ)	+4.97%
Owned by Insiders (%)	1.89%
Owned by Institutions (%)	0.98%
Float	27.05M

Valuation Ratios

The trailing PE ratio is 264.43 and the forward PE ratio is 12.81.

PE Ratio	264.43
Forward PE	12.81
PS Ratio	5.87
PB Ratio	15.16
P/TBV Ratio	20.03
P/FCF Ratio	197.93
P/OCF Ratio	197.39
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 177.76, with an EV/FCF ratio of 183.71.

EV / Earnings	294.10
EV / Sales	5.45
EV / EBITDA	177.76
EV / EBIT	n/a
EV / FCF	183.71

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.88.

Current Ratio	4.47
Quick Ratio	4.26
Debt / Equity	0.88
Debt / EBITDA	11.10
Debt / FCF	11.47
Interest Coverage	2.70

Financial Efficiency

Return on equity (ROE) is 11.78% and return on invested capital (ROIC) is 2.83%.

Return on Equity (ROE)	11.78%
Return on Assets (ROA)	1.81%
Return on Invested Capital (ROIC)	2.83%
Return on Capital Employed (ROCE)	2.03%
Weighted Average Cost of Capital (WACC)	6.23%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.95
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +144.55% in the last 52 weeks. The beta is 0.41, so TSXV:NURS's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+144.55%
50-Day Moving Average	3.85
200-Day Moving Average	3.50
Relative Strength Index (RSI)	27.48
Average Volume (20 Days)	102,041

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NURS had revenue of CAD 24.48 million and earned 453,235 in profits. Earnings per share was 0.01.

Revenue	24.48M
Gross Profit	7.14M
Operating Income	362,248
Pretax Income	453,235
Net Income	453,235
EBITDA	749,891
EBIT	362,248
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 18.64 million in cash and 8.32 million in debt, giving a net cash position of 10.31 million or 0.19 per share.

Cash & Cash Equivalents	18.64M
Total Debt	8.32M
Net Cash	10.31M
Net Cash Per Share	0.19
Equity (Book Value)	9.47M
Book Value Per Share	0.20
Working Capital	15.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 727,566 and capital expenditures -1,995, giving a free cash flow of 725,571.

Operating Cash Flow	727,566
Capital Expenditures	-1,995
Free Cash Flow	725,571
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 29.16%, with operating and profit margins of 1.48% and 1.85%.

Gross Margin	29.16%
Operating Margin	1.48%
Pretax Margin	1.85%
Profit Margin	1.85%
EBITDA Margin	3.06%
EBIT Margin	1.48%
FCF Margin	2.96%

Dividends & Yields

TSXV:NURS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.27%
Shareholder Yield	-13.27%
Earnings Yield	0.32%
FCF Yield	0.51%

Stock Splits

The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.

Last Split Date	Nov 25, 2022
Split Type	Reverse
Split Ratio	0.1546061

Scores

TSXV:NURS has an Altman Z-Score of 5.21 and a Piotroski F-Score of 5.

Altman Z-Score	5.21
Piotroski F-Score	5